Sub-pathway based approach to systematically track candidate sub-pathway biomarkers for heart failure

Han,Dong-Mei

doi:10.3892/etm.2019.7319

Sub-pathway based approach to systematically track candidate sub-pathway biomarkers for heart failure

Authors:
- Dong-Mei Han
View Affiliations

Affiliations: Department of Cardiology, General Hospital of Daqing Oil Field, Daqing, Heilongjiang 163000, P.R. China
Published online on: February 26, 2019 https://doi.org/10.3892/etm.2019.7319
Pages: 3162-3168
Copyright: © Han . This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Identification of potential novel biomarkers for heart failure was undertaken using a sub-pathway based method. To realize this goal, heart failure-relevant dataset, reference pathways, and lncRNA-miRNA-mRNA interactions were firstly recruited. Secondly, the informative pathways were extracted relying on KEGG pathways and the mRNAs in the PCC-weighted lncRNA-mRNA interactions. Thirdly, lncRNA-regulated sub-pathways were dissected after construction of condition-specific lncRNA competitively regulated pathways (LCRP). To detect crucial heart failure-relevant lncRNAs, degree analysis was conducted for all nodes within the LCRP. Ultimately, the significance of candidate sub-pathways were assessed to further identify the significant sub-pathways. There were 44 lncRNAs, 165 mRNAs and 224 co-expressed interactions. After putting the 165 mRNAs into the reference pathways, 56 informative pathways were obtained which were then embedded into undirected graphs, and 44 lncRNAs were inserted into the pathway graphs to further construct the condition-specific LCRP. According to degree distribution, 4 hub lncRNAs were selected, including ERVK13-1, YLPM1, PDXDC2P, and LINC00482. Based on the LCRP information, a total of 36 sub-pathways mediated by lncRNAs participated in 40 complete pathways. Among these 40 pathways, we mainly concentrated on the top three sub-pathways, including a sub‑part of MAPK signaling pathway, an important sub‑part in ErbB signaling pathway, and a part of chemokine signaling pathway. In the top 3 significant sub-pathways, gene AKT3 was simultaneously regulated by ERVK13-1, YLPM1, and PDXDC2P. Sub-pathways including MAPK signaling pathway and hub lncRNAs (ERVK13-1, YLPM1, and PDXDC2P) may play an important role in heart failure.

View Figures

View References

1	McMurray JJ and Pfeffer MA: Heart failure. Lancet. 365:1877–1889. 2005. View Article : Google Scholar : PubMed/NCBI
2	Charlson FJ, Erskine HE, Ferrari AJ, Leung J, Whiteford HA, Abajobir AA, Knibbs LD, Lalloo R, Scott JG and Guo Y; GBD 2015 Disease and Injury Incidence and Prevalence Collaborators, : Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet. 388:1545–1602. 2016. View Article : Google Scholar : PubMed/NCBI
3	Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, et al American Heart Association Statistics Committee and Stroke Statistics Subcommittee, : Executive summary: heart disease and stroke statistics - 2013 update: a report from the American Heart Association. Circulation. 127:143–152. 2013. View Article : Google Scholar : PubMed/NCBI
4	Kusumoto A, Miyata M, Kubozono T, Ikeda Y, Shinsato T, Kuwahata S, Fujita S, Takasaki K, Yuasa T, Hamasaki S, et al: Highly sensitive cardiac troponin T in heart failure: Comparison with echocardiographic parameters and natriuretic peptides. J Cardiol. 59:202–208. 2012. View Article : Google Scholar : PubMed/NCBI
5	Di Gesualdo F, Capaccioli S and Lulli M: A pathophysiological view of the long non-coding RNA world. Oncotarget. 5:10976–10996. 2014. View Article : Google Scholar : PubMed/NCBI
6	Zhao W, Luo J and Jiao S: Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications. Sci Rep. 4:65912014. View Article : Google Scholar : PubMed/NCBI
7	Gomes da Silva AM and Silbiger VN: miRNAs as biomarkers of atrial fibrillation. Biomarkers. 19:631–636. 2014. View Article : Google Scholar : PubMed/NCBI
8	Liang WC, Fu WM, Wong CW, Wang Y, Wang WM, Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF, et al: The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget. 6:22513–22525. 2015. View Article : Google Scholar : PubMed/NCBI
9	Papait R, Kunderfranco P, Stirparo GG, Latronico MVG and Condorelli G: Long noncoding RNA: A new player of heart failure? J Cardiovasc Transl Res. 6:876–883. 2013. View Article : Google Scholar : PubMed/NCBI
10	Han P, Li W, Lin CH, Yang J, Shang C, Nuernberg ST, Jin KK, Xu W, Lin CY, Lin CJ, et al: A long noncoding RNA protects the heart from pathological hypertrophy. Nature. 514:102–106. 2014. View Article : Google Scholar : PubMed/NCBI
11	Shi X, Xu Y, Zhang C, Feng L, Sun Z, Han J, Su F, Zhang Y, Li C and Li X: Subpathway-LNCE: Identify dysfunctional subpathways competitively regulated by lncRNAs through integrating lncRNA-mRNA expression profile and pathway topologies. Oncotarget. 7:69857–69870. 2016. View Article : Google Scholar : PubMed/NCBI
12	Li C, Han J, Yao Q, Zou C, Xu Y, Zhang C, Shang D, Zhou L, Zou C, Sun Z, et al: Subpathway-GM: Identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways. Nucleic Acids Res. 41:e1012013. View Article : Google Scholar : PubMed/NCBI
13	Li X, Shen L, Shang X and Liu W: Subpathway analysis based on signaling-pathway impact analysis of signaling pathway. PLoS One. 10:e01328132015. View Article : Google Scholar : PubMed/NCBI
14	Greco S, Fasanaro P, Castelvecchio S, D'Alessandra Y, Arcelli D, Di Donato M, Malavazos A, Capogrossi MC, Menicanti L and Martelli F: MicroRNA dysregulation in diabetic ischemic heart failure patients. Diabetes. 61:1633–1641. 2012. View Article : Google Scholar : PubMed/NCBI
15	Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B and Speed TP: Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31:e152003. View Article : Google Scholar : PubMed/NCBI
16	Bolstad BM, Irizarry RA, Astrand M and Speed TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 19:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
17	Wang HB, Jiang ZB and Li M: Research on the typical miRNA and target genes in squamous cell carcinoma and adenocarcinoma of esophagus cancer with DNA microarray. Pathol Oncol Res. 20:245–252. 2014. View Article : Google Scholar : PubMed/NCBI
18	Nahler G: Pearson correlation coefficient. Dictionary of Pharmaceutical Medicine. Springer-Verlag Vienna; Austria: pp. 1322009, View Article : Google Scholar
19	Best DJ and Roberts DE: Algorithm AS 89: The upper tail probabilities of Spearman's Rho. Appl Stat. 24:377–379. 1975. View Article : Google Scholar
20	Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, et al: KEGG for linking genomes to life and the environment. Nucleic Acids Res. 36:D480–D484. 2008. View Article : Google Scholar : PubMed/NCBI
21	Benjamini Y and Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B. 57:289–300. 1995.
22	Epstein MP, Duncan R, Jiang Y, Conneely KN, Allen AS and Satten GA: A permutation procedure to correct for confounders in case-control studies, including tests of rare variation. Am J Hum Genet. 91:215–223. 2012. View Article : Google Scholar : PubMed/NCBI
23	Molkentin JD and Dorn GW II: Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol. 63:391–426. 2001. View Article : Google Scholar : PubMed/NCBI
24	Kim ES, Kim MS and Moon A: TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int J Oncol. 25:1375–1382. 2004.PubMed/NCBI
25	Qiu Q, Yang M, Tsang BK and Gruslin A: EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathways. Reproduction. 128:355–363. 2004. View Article : Google Scholar : PubMed/NCBI
26	Ulke-Lemée A, Trinkle-Mulcahy L, Chaulk S, Bernstein NK, Morrice N, Glover M, Lamond AI and Moorhead GBG: The nuclear PP1 interacting protein ZAP3 (ZAP) is a putative nucleoside kinase that complexes with SAM68, CIA, NF110/45, and HNRNP-G. Biochim Biophys Acta. 1774:1339–1350. 2007. View Article : Google Scholar : PubMed/NCBI
27	Armstrong L, Lako M, van Herpe I, Evans J, Saretzki G and Hole N: A role for nucleoprotein Zap3 in the reduction of telomerase activity during embryonic stem cell differentiation. Mech Dev. 121:1509–1522. 2004. View Article : Google Scholar : PubMed/NCBI
28	Leri A, Franco S, Zacheo A, Barlucchi L, Chimenti S, Limana F, Nadal-Ginard B, Kajstura J, Anversa P and Blasco MA: Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J. 22:131–139. 2003. View Article : Google Scholar : PubMed/NCBI
29	Shiojima I and Walsh K: Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev. 20:3347–3365. 2006. View Article : Google Scholar : PubMed/NCBI
30	Chaanine AH and Hajjar RJ: AKT signalling in the failing heart. Eur J Heart Fail. 13:825–829. 2011. View Article : Google Scholar : PubMed/NCBI